Get notified when INNV files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts

Red Flags Detected

  • Civil Investigative Demand (worsened) — The company recorded a $37.0 million litigation accrual related to the 2021 and 2022 DOJ civil investigative demands, whereas the prior year stated it was unable to estimate possible losses.
NASDAQ: INNV InnovAge Holding Corp. 10-K

InnovAge swings to operating income on 15.9% revenue growth, but $989.7M DOJ accrual and Medicaid cuts loom

Filed September 9, 2026 · Period ending June 30, 2026 · Compared to 10-K Sep 9, 2025 · ~1 min read

Key Changes

  • high

    Revenue rose 15.9% to $989.7M, and operating income swung from a loss, driven by higher capitation rates and enrollment.

  • high

    Net loss narrowed, but a litigation expense increase, including a accrual for DOJ civil investigative demands, weighed on results.

    MD&A / Notes view on EDGAR →
  • high

    California paused all new PACE center applications for at least two years, and Colorado Medicaid premium rates are expected to decrease retroactively to July 1, 2026.

2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (ORCL 10-Q) is open in full — no account needed.

Partner

Trade INNV commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Figures/quotes linked to EDGAR · Narrative written by AI · Sep 11, 2026 · How we verify